Bayesian Capital Management, LP Rocket Pharmaceuticals, Inc. Transaction History
Bayesian Capital Management, LP
- $582 Million
- Q1 2025
A detailed history of Bayesian Capital Management, LP transactions in Rocket Pharmaceuticals, Inc. stock. As of the latest transaction made, Bayesian Capital Management, LP holds 20,536 shares of RCKT stock, worth $56,884. This represents 0.02% of its overall portfolio holdings.
Number of Shares
20,536
Previous 29,536
30.47%
Holding current value
$56,884
Previous $371,000
63.34%
% of portfolio
0.02%
Previous 0.05%
Shares
3 transactions
Others Institutions Holding RCKT
# of Institutions
258Shares Held
108MCall Options Held
555KPut Options Held
177K-
Rtw Investments, LP New York, NY17.7MShares$49 Million1.93% of portfolio
-
Wellington Management Group LLP Boston, MA12.6MShares$35 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.62MShares$18.3 Million0.0% of portfolio
-
Black Rock Inc. New York, NY6.19MShares$17.2 Million0.0% of portfolio
-
Lee Ainslie Maverick Capital LTD | Dallas, Tx5.2MShares$14.4 Million0.68% of portfolio
About ROCKET PHARMACEUTICALS, INC.
- Ticker RCKT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 75,683,696
- Market Cap $210M
- Description
- Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a multi-platform biotechnology company that focuses on developing gene therapies for rare and devastating diseases. It has three clinical-stage ex vivo lentiviral vector programs for fanconi anemia, a genetic defect in the bone marrow that reduces production of blood cells...